Sinotherapeutics Inc. A

SHG:688247 China Drug Manufacturers - Specialty & Generic

Market Cap

$600.56 Million

CN¥4.41 Billion CNY

Market Cap Rank

#17031 Global

#4468 in China

Share Price

CN¥9.72

Change (1 day)

-1.02%

52-Week Range

CN¥9.06 - CN¥13.01

All Time High

CN¥25.98

Sinotherapeutics Inc. A - Asset Resilience Ratio

Latest as of June 2025: 37.00%

Sinotherapeutics Inc. A (688247) has an Asset Resilience Ratio of 37.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥534.11 Million

Cash + Short-term Investments

Total Assets

CN¥1.44 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2024–2024)

This chart shows how Sinotherapeutics Inc. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Sinotherapeutics Inc. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥534.11 Million	37.0%
Total Liquid Assets	CN¥534.11 Million	37.00%

Asset Resilience Insights

Very High Liquidity: Sinotherapeutics Inc. A maintains exceptional liquid asset reserves at 37.00% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.